{"name":"Relay Therapeutics, Inc.","slug":"relay-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":15355000,"revenueGrowth":53.4,"grossMargin":0,"rdSpend":99862000,"netIncome":-276479000,"cash":84018000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPQXlaN3J5M0FwRUNUTjBOWkh6cWRuWjZnY3EyeEtHUEJWNHFKV1VVRmFfNEdGa2tmeHdRekE3LThMeUdndVY0LUdJTF90eW4xYjl3dGE0bTFyeHJOX3Vjak1EcmJVYTNQVk53aW9OaEF4VVZmQjYxOHVFMzFQazlSX0pmcFI0MHdhQ3ZZYnhnSzctX1lzRUU0WlRJVjJZSGY1bEU0eVdURm5CVFhRLWpmT2NDQTVybXZ5V1QzaldzQTgzaElWeVpUcmRkbjNQY2g5a3VzVg?oc=5","date":"2026-04-04","type":"pipeline","source":"AAII","summary":"Which Is a Better Investment, ACADIA Pharmaceuticals Inc. or Relay Therapeutics, Inc. Stock? - AAII","headline":"Which Is a Better Investment, ACADIA Pharmaceuticals Inc. or Relay Therapeutics, Inc. Stock?","sentiment":"neutral"},{"date":"2026-03-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPNXN3blU2aURkdU9TWDdJTWJ5OWR1eFRuQ1d4YXVYMjJNbnFjQ25SVWJablZWcHpMaHhUN2x4Mm5hRkN3TE84bjc3S1V6YThrem95bjFnRnlFS2FaWVdTWEJ6alJ4Yjl1WDJpMUtCSl9fakt6cW5rcmpfQ2EyNGFYSHd3?oc=5","date":"2026-02-27","type":"pipeline","source":"AOL.com","summary":"Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million - AOL.com","headline":"Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOOFkzYnZha2RJZTdWTDlSbWxQMGYyeE01SUdsODNPcTFkYmJTcWcxOXBIV2VSUUFKWEVXMmdlLTRyY1M0bXpOUl9CZ0diUVRuSHBuLXFCTVpIUWN3Ymp1ZUdBazhiQ1VRQ2ZnOXppVGNYZ2V6RUlpaWlWNDBUel9sSzJYZGZLSGZqdW5FX2Utd0pwWVlILURxQ2cxTEhuM1BOZlN1MVVR?oc=5","date":"2026-02-03","type":"regulatory","source":"The Pharma Letter","summary":"Relay Thera’s zovegalisib wins ‘Breakthrough’ status from FDA - The Pharma Letter","headline":"Relay Thera’s zovegalisib wins ‘Breakthrough’ status from FDA","sentiment":"neutral"},{"date":"2026-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxObnlRZjlVdldSekZURTdVOVdSY3pXclY4emI1Mzd4cXI0QVRJOXVnM1NXY1lxaDlGb2lDUFRmN2tmNmNEZUxybjJ2N0o4WEt2Q2pOMVhrOUV5S01LS1Rzek9lRllZQzNzeFItbWt6VnNfN1UtQXRuVmVGUk9RM0lkNElyVjhwd0k?oc=5","date":"2026-01-19","type":"pipeline","source":"Finviz","summary":"Agios Pharmaceuticals, Inc. (AGIO): A Bull Case Theory - Finviz","headline":"Agios Pharmaceuticals, Inc. (AGIO): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPRC1PRHl2d0x5bnUtS09vV1dfQmRYU3BzVjhMSjQya0NfSkxDSzJqa0FwVWxUQ2lMaHpDOWNNSmo0Y21QNjBIbkhYVTlNcEpoaWdLN2JidS1fcmZObmk3V1ZMN0JMM0ZZQS1wd2FqLWJydVFNaXlHSmxXT2Y3TWNTVnBTcVVVbHdtR0NlcGwwZGhJTmpYQnhQZVd1emF1eGh4ek9penRSeEcyMXQ3WTNMYUxR?oc=5","date":"2025-11-06","type":"earnings","source":"Investing News Network","summary":"Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - Investing News Network","headline":"Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1ZU3JQQlFNQVJmdmdkWm5GYUVBM2NQc1FZdEJjNzZfaUhVVVp3bEl5RzZpYV82OWpLV1ROd2JPWHZFaHBycW5QbzYwX2lQdlA4c0dydXE3c3IxXzRVTjVESmYtUGhObTNhRGFLVkdrOA?oc=5","date":"2025-09-29","type":"pipeline","source":"TradingKey","summary":"Healthcare Sector: Companies, Performance and Stocks - TradingKey","headline":"Healthcare Sector: Companies, Performance and Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNOWlfRkNtRlRUWnBEcUdFTjdtbkREdUNNTXUxNDhWU3Y1dHFfTE5Cdk1MRWs5MWlySWRpTkdRYWh4SFhwT1FRemtGLVM0VFBSNmtvX0lvNzczTGZJMUxSWGtlN0xKMWxxOEpOWUo0ZmVfeDVpQVF6OFZVdUk5WEQ5Ync3QjNBTzk2dWlybnp6YVN2MElFYVFsb1BObExFcnpNWjJxQmJ0YUpFMkhzcGVWMXpxZklWRUdwS3RwNXlPZTVnUHBLUERlUWNBY2ZTUQ?oc=5","date":"2025-09-18","type":"trial","source":"Investing.com","summary":"Relay Therapeutics’ SWOT analysis: AI-driven biotech stock faces pivotal phase - Investing.com","headline":"Relay Therapeutics’ SWOT analysis: AI-driven biotech stock faces pivotal phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQdVg0MVlwQlo1X3dSamVEVHY5aUtleGZPWll5alA2X1V6YkJwcDN0bHJTeThibDF5U25hYWg3SU4xdnVVcTRMSkQ4ZDY1Y2dyN1hyd05nM09PNG9PM1FKaC1kdDBoV0ZHdVJncDdpaW54bHRiMUs4UEZiZXA5QVgzQWphZndhZUU0RmZfYXlWSTl3Zm5aZHJjTF8zRkZ5RkRpR0xCeDExRGcwWFdacDE0MFktcDBWRllCSkE?oc=5","date":"2025-07-25","type":"pipeline","source":"TradingView","summary":"RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - TradingView","headline":"RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOR1dLMEFydmhBWHhjWXRPZTdBYTJCaHd0ZE51WTRPcldUdnZkTUNMWloxVlpKSGV4a1duZmNEcDN2V19yYUxGSlFJblJmcTRCdEZSVFVOc3ZSekJ2NmFZVERnemJVQ19GWklhRlZRY2dhV08yXzhCbkkwZkg5UGFOUUtDNndhdmd6NldwZTFlNUs5TEh4TDJj?oc=5","date":"2025-07-16","type":"deal","source":"Yahoo Finance","summary":"Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Yahoo Finance","headline":"Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOSVQzMkNRLW1EQmlPY0c4bjZLelpDNVBOZTZ6dTYtc1ZmX1ZYMDUwS3o2b3MzWUx2M2l3Uk96NXFmSGYyS3pXN1NDajliUnQzU1NxcUtQNENRZHRNQ3djLVZkSlA5U3lrU2ttYXcyX21UZHJYQXZjcXhFYW14dkxjNjhYUjE5enFpQmVaOS1lQUpWWXA5Y3VtUUxSdnNtSENycFE3aGt5U01lYkFVcWZBVE5tdXRDZXFHMU85aUhwWi1hVDc2LXVmSXVFejd6LU84a1pVZkVQTGluZXNZS2MwRFVJLWY4bmtrSkE?oc=5","date":"2025-07-02","type":"pipeline","source":"The Globe and Mail","summary":"Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - The Globe and Mail","headline":"Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":15355000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":15355000,"period":"2025-12-31"},{"value":10007000,"period":"2024-12-31"},{"value":25546000,"period":"2023-12-31"},{"value":1381000,"period":"2022-12-31"},{"value":30290000,"period":"2021-12-31"},{"value":82654000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":99862000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-276479000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":84018000,"cashHistory":[],"totalAssets":621331000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}